New York State Common Retirement Fund Eagle Pharmaceuticals, Inc. Transaction History

New York State Common Retirement Fund

$73.9 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 31, 2024	SELL	$3.34 - $5.6 $21,042 - $35,280	-6,300 Reduced 98.59%	90 $1,000
Q4 2023 Feb 01, 2024	SELL	$4.63 - $15.21 $111 - $365	-24 Reduced 0.37%	6,390 $33,000
Q3 2023 Nov 07, 2023	SELL	$15.21 - $22.88 $135,445 - $203,746	-8,905 Reduced 58.13%	6,414 $101,000
Q2 2023 Aug 07, 2023	SELL	$17.74 - $31.87 $30,548 - $54,880	-1,722 Reduced 10.11%	15,319 $298,000
Q1 2023 May 02, 2023	SELL	$25.06 - $34.09 $238,646 - $324,639	-9,523 Reduced 35.85%	17,041 $483,000
Q4 2022 Jan 30, 2023	BUY	$24.98 - $39.77 $453,986 - $722,779	18,174 Added 216.62%	26,564 $776,000
Q3 2022 Nov 08, 2022	BUY	$26.42 - $47.12 $343 - $612	13 Added 0.16%	8,390 $222,000
Q2 2022 Aug 04, 2022	SELL	$41.26 - $51.35 $1,155 - $1,437	-28 Reduced 0.33%	8,377 $372,000
Q1 2022 May 05, 2022	BUY	$44.58 - $52.6 $312 - $368	7 Added 0.08%	8,405 $416,000
Q4 2021 Feb 02, 2022	SELL	$45.82 - $56.9 $1,466 - $1,820	-32 Reduced 0.38%	8,398 $428,000
Q3 2021 Nov 02, 2021	SELL	$43.79 - $55.78 $94,323 - $120,150	-2,154 Reduced 20.35%	8,430 $470,000
Q2 2021 Aug 02, 2021	BUY	$36.86 - $44.5 $3,096 - $3,738	84 Added 0.8%	10,584 $453,000
Q1 2021 May 11, 2021	SELL	$40.32 - $50.97 $44,352 - $56,067	-1,100 Reduced 9.48%	10,500 $438,000
Q2 2020 Aug 07, 2020	BUY	$43.24 - $55.02 $90,804 - $115,542	2,100 Added 22.11%	11,600 $557,000
Q3 2019 Nov 07, 2019	SELL	$53.25 - $59.98 $589,743 - $664,278	-11,075 Reduced 53.83%	9,500 $537,000
Q2 2019 Aug 09, 2019	BUY	$46.61 - $58.45 $276,816 - $347,134	5,939 Added 40.58%	20,575 $1.15 Million
Q4 2018 Feb 08, 2019	SELL	$36.72 - $67.73 $2.09 Million - $3.86 Million	-56,997 Reduced 79.57%	14,636 $590,000
Q3 2018 Nov 07, 2018	BUY	$66.65 - $83.86 $561,326 - $706,268	8,422 Added 13.32%	71,633 $4.97 Million
Q2 2018 Aug 10, 2018	SELL	$51.25 - $76.62 $64,370 - $96,234	-1,256 Reduced 1.95%	63,211 $4.78 Million
Q1 2018 May 10, 2018	BUY	$52.16 - $66.86 $116,525 - $149,365	2,234 Added 3.59%	64,467 $3.4 Million
Q4 2017 Feb 13, 2018	BUY	$49.6 - $60.87 $556,164 - $682,535	11,213 Added 21.98%	62,233 $3.32 Million
Q3 2017 Nov 06, 2017	SELL	$46.62 - $60.36 $22,517 - $29,153	-483 Reduced 0.94%	51,020 $3.04 Million
Q2 2017 Aug 11, 2017	BUY	N/A	51,503	51,503 $4.06 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account